ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $26,756,000 | -3.9% | 5,449,340 | +3.4% | 0.00% | 0.0% |
Q2 2021 | $27,838,000 | +13.0% | 5,272,400 | +2.8% | 0.00% | 0.0% |
Q1 2021 | $24,627,000 | +2462600.0% | 5,130,723 | +1710141.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 300 | +140.0% | 0.00% | – |
Q1 2019 | $1,000 | -100.0% | 125 | -100.0% | 0.00% | -100.0% |
Q3 2018 | $6,484,000 | -76.6% | 323,869 | -69.8% | 0.00% | -66.7% |
Q2 2018 | $27,734,000 | -17.9% | 1,073,702 | -24.0% | 0.00% | -25.0% |
Q1 2018 | $33,776,000 | -34.8% | 1,413,202 | -7.6% | 0.00% | -33.3% |
Q4 2017 | $51,832,000 | +11.7% | 1,529,404 | -30.2% | 0.01% | 0.0% |
Q3 2017 | $46,394,000 | +7.6% | 2,191,481 | -11.1% | 0.01% | +20.0% |
Q2 2017 | $43,099,000 | -0.1% | 2,464,181 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $43,123,000 | -6.7% | 2,464,181 | -9.9% | 0.01% | -16.7% |
Q4 2016 | $46,204,000 | +3.0% | 2,733,981 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $44,865,000 | +2.3% | 2,733,981 | -5.6% | 0.01% | 0.0% |
Q2 2016 | $43,853,000 | +2.2% | 2,896,481 | -2.4% | 0.01% | 0.0% |
Q1 2016 | $42,895,000 | -45.1% | 2,966,481 | +7.5% | 0.01% | -45.5% |
Q4 2015 | $78,180,000 | +69.2% | 2,760,581 | 0.0% | 0.01% | +57.1% |
Q3 2015 | $46,212,000 | -34.1% | 2,760,581 | +3.3% | 0.01% | -22.2% |
Q2 2015 | $70,098,000 | +54.5% | 2,673,456 | +3.1% | 0.01% | +50.0% |
Q1 2015 | $45,374,000 | +31.1% | 2,594,267 | +30.2% | 0.01% | +20.0% |
Q4 2014 | $34,608,000 | +22.0% | 1,992,427 | +30.8% | 0.01% | +25.0% |
Q3 2014 | $28,368,000 | +19.4% | 1,523,513 | +17.2% | 0.00% | +33.3% |
Q2 2014 | $23,759,000 | – | 1,299,741 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|